OTL 204
Alternative Names: OTL204Latest Information Update: 02 Feb 2024
At a glance
- Originator University of Padua
- Developer Orchard Therapeutics; University of Padua
- Class Antidementias; Gene therapies; Haematopoietic stem cells therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Frontotemporal dementia